PL399447A1 - Szczepionka do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnazania komórek Treg do wytwarzania szczepionki do leczenia cukrzycy typu 1 - Google Patents
Szczepionka do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnazania komórek Treg do wytwarzania szczepionki do leczenia cukrzycy typu 1Info
- Publication number
- PL399447A1 PL399447A1 PL399447A PL39944712A PL399447A1 PL 399447 A1 PL399447 A1 PL 399447A1 PL 399447 A PL399447 A PL 399447A PL 39944712 A PL39944712 A PL 39944712A PL 399447 A1 PL399447 A1 PL 399447A1
- Authority
- PL
- Poland
- Prior art keywords
- vaccine
- diabetes
- treatment
- type
- children
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title abstract 3
- 210000004027 cell Anatomy 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 210000003289 regulatory T cell Anatomy 0.000 title abstract 2
- 230000035755 proliferation Effects 0.000 title 1
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 abstract 1
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 abstract 1
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 230000001902 propagating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0637—Immunosuppressive T lymphocytes, e.g. regulatory T cells or Treg
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Przedmiotem wynalazku jest szczepionka do leczenia cukrzycy typu 1 u dzieci, która zawiera limfocyty Treg CD3(+)CD4(+)CD25(high)CD127(-). Ponadto ujawniono sorter komórek do wytwarzania tej szczepionki oraz sposób namnazania komórek Treg in vitro.
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL399447A PL218400B1 (pl) | 2012-06-06 | 2012-06-06 | Szczepionka do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnażania komórek Treg in vitro do wytwarzania szczepionki do leczenia cukrzycy typu 1 |
PCT/PL2013/000072 WO2013184011A1 (en) | 2012-06-06 | 2013-06-04 | Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying treg cells to produce therapeutic vaccine for treatment of diabetes type 1 |
PL13739523T PL2859092T3 (pl) | 2012-06-06 | 2013-06-04 | Szczepionka terapeutyczna do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnażania komórek Treg do wytwarzania szczepionki do leczenia cukrzycy typu 1 |
DK13739523.2T DK2859092T3 (da) | 2012-06-06 | 2013-06-04 | Terapeutisk vaccine til behandling af diabetes type-1 hos børn, anvendelse af cellesorter og fremgangsmåde til at multiplicere treg-celler til fremstilling af terapeutisk vaccine til behandling af diabetes type-1 |
EP13739523.2A EP2859092B1 (en) | 2012-06-06 | 2013-06-04 | Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying treg cells to produce therapeutic vaccine for treatment of diabetes type 1 |
HUE13739523A HUE057439T2 (hu) | 2012-06-06 | 2013-06-04 | Terápiás vakcina 1-es típusú cukorbetegség kezelésére gyermekekben, sejtválogató alkalmazása és eljárás TREG sejtek sokszorosítására 1-es típusú cukorbetegség kezelésére szolgáló terápiás vakcina elõállítására |
US14/405,906 US20150165007A1 (en) | 2012-06-06 | 2013-06-04 | Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying treg cells to produce therapeutic vaccine for treatment of diabetes type 1 |
ES13739523T ES2807279T3 (es) | 2012-06-06 | 2013-06-04 | Vacuna terapéutica para el tratamiento de la diabetes de tipo 1 en niños, aplicación del separador celular y método de multiplicación de células Treg para producir vacuna terapéutica para el tratamiento de la diabetes de tipo 1 |
SI201331762T SI2859092T1 (sl) | 2012-06-06 | 2013-06-04 | Terapevtsko cepivo za zdravljenje diabetesa tipa 1 pri otrocih, uporaba naprave za sortiranje celic in postopek multipliciranja TREG celic za pridobivanje terapevtskega cepiva za zdravljenje diabetesa tipa 1 |
LTEP13739523.2T LT2859092T (lt) | 2012-06-06 | 2013-06-04 | Terapinė vakcina, skirta vaikų 1 tipo diabeto gydymui, ląstelių sorterio taikymas ir treg ląstelių dauginimo būdas, siekiant gaminti terapinę vakciną 1 tipo diabeto gydymui |
PT137395232T PT2859092T (pt) | 2012-06-06 | 2013-06-04 | ¿vacina terapêutica para tratamento de diabetes tipo 1 em crianças, aplicação do separador de células e método de multiplicação de células treg para produzir a vacina terapêutica para tratamento de diabetes tipo 1¿ |
US15/852,227 US11944672B2 (en) | 2012-06-06 | 2017-12-22 | Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying Treg cells to produce therapeutic vaccine for treatment of diabetes type 1 |
US16/661,038 US20200054724A1 (en) | 2012-06-06 | 2019-10-23 | Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying treg cells to produce therapeutic vaccine for treatment of diabetes type 1 |
HRP20201177TT HRP20201177T1 (hr) | 2012-06-06 | 2020-07-28 | Terapijsko cjepivo za liječenje dijabetesa tipa 1 kod djece, primjena staničnog sortera i metoda umnožavanja treg stanica za proizvodnju terapijskog cjepiva za liječenje dijabetesa tipa 1 |
CY20201101056T CY1123467T1 (el) | 2012-06-06 | 2020-07-29 | Θεραπευτικο εμβολιο για τη θεραπεια του παιδικου διαβητη τυπου 1, εφαρμογη του κυτταροδιαχωριστη κυτταρομετριας ροης και της μεθοδου πολλαπλασιασμου των κυτταρων treg για την παραγωγη θεραπευτικου εμβολιου για τη θεραπεια του διαβητη τυπου 1 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL399447A PL218400B1 (pl) | 2012-06-06 | 2012-06-06 | Szczepionka do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnażania komórek Treg in vitro do wytwarzania szczepionki do leczenia cukrzycy typu 1 |
Publications (2)
Publication Number | Publication Date |
---|---|
PL399447A1 true PL399447A1 (pl) | 2013-12-09 |
PL218400B1 PL218400B1 (pl) | 2014-11-28 |
Family
ID=48808489
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL399447A PL218400B1 (pl) | 2012-06-06 | 2012-06-06 | Szczepionka do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnażania komórek Treg in vitro do wytwarzania szczepionki do leczenia cukrzycy typu 1 |
PL13739523T PL2859092T3 (pl) | 2012-06-06 | 2013-06-04 | Szczepionka terapeutyczna do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnażania komórek Treg do wytwarzania szczepionki do leczenia cukrzycy typu 1 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13739523T PL2859092T3 (pl) | 2012-06-06 | 2013-06-04 | Szczepionka terapeutyczna do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnażania komórek Treg do wytwarzania szczepionki do leczenia cukrzycy typu 1 |
Country Status (12)
Country | Link |
---|---|
US (3) | US20150165007A1 (pl) |
EP (1) | EP2859092B1 (pl) |
CY (1) | CY1123467T1 (pl) |
DK (1) | DK2859092T3 (pl) |
ES (1) | ES2807279T3 (pl) |
HR (1) | HRP20201177T1 (pl) |
HU (1) | HUE057439T2 (pl) |
LT (1) | LT2859092T (pl) |
PL (2) | PL218400B1 (pl) |
PT (1) | PT2859092T (pl) |
SI (1) | SI2859092T1 (pl) |
WO (1) | WO2013184011A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170232084A1 (en) | 2013-04-26 | 2017-08-17 | Enzo Biochem Inc. | Immune modulation for the treatment of age-related macular degeneration |
PL236046B1 (pl) | 2015-12-17 | 2020-11-30 | Gdanski Univ Medyczny | Sposób namnażania in vitro limfocytów T regulatorowych CD4+ FoxP3+ |
US20220204931A1 (en) * | 2019-04-30 | 2022-06-30 | The Regents Of The University Of California | Bead-free ex-vivo expansion of human regulatory t cells |
EP3985106A1 (en) | 2020-10-16 | 2022-04-20 | Uniwersytet Gdanski | Conditioned regulatory t cell population with enhanced therapeutic potential, method for obtaining of regulatory t cell population and the medical use of regulatory t cell population |
EP3985105A1 (en) | 2020-10-16 | 2022-04-20 | Uniwersytet Gdanski | Conditioned regulatory t cell population tregs with enhanced therapeutic potential, method for obtaining of conditioned tregs and the medical use of the tregs population |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006526651A (ja) | 2003-06-02 | 2006-11-24 | マーシア・ファーマ・インコーポレイテッド | 1型糖尿病の処置のための治療的ワクチン組成物 |
JP2006280307A (ja) * | 2005-04-01 | 2006-10-19 | Kyoto Univ | 制御性t細胞の製造方法 |
EP1928479B1 (en) * | 2005-08-24 | 2016-06-08 | Yeda Research And Development Co., Ltd. | Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance |
US20090208471A1 (en) * | 2006-04-07 | 2009-08-20 | Yun Theodore J | Isolation and Use of Human Regulatory T Cells |
WO2007127787A2 (en) * | 2006-04-25 | 2007-11-08 | Joslin Diabetes Center, Inc. | Insulin autoantigen-specific regulatory cd4+ t cells |
EP2402029A1 (en) | 2010-07-01 | 2012-01-04 | Sanofi Pasteur | Enterovirus vaccines for preventing or treating type 1 diabetes (III) |
EP2402028A1 (en) | 2010-07-01 | 2012-01-04 | Sanofi Pasteur | Enterovirus vaccines for preventing and treating type 1 diabetes (II) |
US9481866B2 (en) * | 2011-12-16 | 2016-11-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of producing T cell populations enriched for stable regulatory T-cells |
-
2012
- 2012-06-06 PL PL399447A patent/PL218400B1/pl unknown
-
2013
- 2013-06-04 PL PL13739523T patent/PL2859092T3/pl unknown
- 2013-06-04 PT PT137395232T patent/PT2859092T/pt unknown
- 2013-06-04 DK DK13739523.2T patent/DK2859092T3/da active
- 2013-06-04 HU HUE13739523A patent/HUE057439T2/hu unknown
- 2013-06-04 WO PCT/PL2013/000072 patent/WO2013184011A1/en active Application Filing
- 2013-06-04 SI SI201331762T patent/SI2859092T1/sl unknown
- 2013-06-04 ES ES13739523T patent/ES2807279T3/es active Active
- 2013-06-04 US US14/405,906 patent/US20150165007A1/en not_active Abandoned
- 2013-06-04 EP EP13739523.2A patent/EP2859092B1/en active Active
- 2013-06-04 LT LTEP13739523.2T patent/LT2859092T/lt unknown
-
2017
- 2017-12-22 US US15/852,227 patent/US11944672B2/en active Active
-
2019
- 2019-10-23 US US16/661,038 patent/US20200054724A1/en not_active Abandoned
-
2020
- 2020-07-28 HR HRP20201177TT patent/HRP20201177T1/hr unknown
- 2020-07-29 CY CY20201101056T patent/CY1123467T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HUE057439T2 (hu) | 2022-05-28 |
EP2859092A1 (en) | 2015-04-15 |
ES2807279T3 (es) | 2021-02-22 |
EP2859092B1 (en) | 2020-04-29 |
PT2859092T (pt) | 2020-07-23 |
WO2013184011A1 (en) | 2013-12-12 |
US20200054724A1 (en) | 2020-02-20 |
SI2859092T1 (sl) | 2021-02-26 |
US20180117134A1 (en) | 2018-05-03 |
PL2859092T3 (pl) | 2020-11-16 |
US20150165007A1 (en) | 2015-06-18 |
US11944672B2 (en) | 2024-04-02 |
HRP20201177T1 (hr) | 2021-02-19 |
LT2859092T (lt) | 2020-09-25 |
CY1123467T1 (el) | 2022-03-24 |
DK2859092T3 (da) | 2020-07-27 |
PL218400B1 (pl) | 2014-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123467T1 (el) | Θεραπευτικο εμβολιο για τη θεραπεια του παιδικου διαβητη τυπου 1, εφαρμογη του κυτταροδιαχωριστη κυτταρομετριας ροης και της μεθοδου πολλαπλασιασμου των κυτταρων treg για την παραγωγη θεραπευτικου εμβολιου για τη θεραπεια του διαβητη τυπου 1 | |
WO2013006474A3 (en) | Requlatora t cells and methods of identifying and isolating them using cd6 -expression or the combination of cd4, cd25 and cd127 | |
CY1123142T1 (el) | Βελτιωμενες μεθοδοι για την παραγωγη θετων κυτταρικων θεραπειων | |
MX2021006932A (es) | Receptores de celulas t humanas con alta afinidad modificados por medio de manipulacion genetica. | |
CY1125057T1 (el) | Anti-cd277 αντισωματα και χρησεις αυτων | |
MX351226B (es) | Celulas t con memoria central anti tercera parte, metodos para producirlas y uso de las mismas en transplante y tratamiento de enfermedades. | |
MX2013014544A (es) | Vectorales de terapia genica para adrenoleucodistrofia y adrenomieloneuropatia. | |
MX2017000646A (es) | Celulas geneticamente modificadas para terapia celular adoptiva. | |
MX2015001871A (es) | Celulas asesinas naturales y usos de las mismas. | |
BR112013002811A8 (pt) | meios básicos simplificados para cultura celular pluripotente de humano | |
MX2015000433A (es) | Uso de cart19 para eliminar celulas b normales para inducir tolerancia. | |
MY178142A (en) | Anti-phf-tau antibodies and their uses | |
EA201790293A2 (ru) | Антитела, направленные против icos, и их применения | |
EA201291157A1 (ru) | Мультивалентные вакцины с синтетическими наноносителями | |
WO2011139628A8 (en) | Generation of anterior foregut endoderm from pluripotent cells | |
EA201290876A1 (ru) | Композиции индуцированных дендритных клеток и их использование | |
CA2866116C (en) | Expansion of alloantigen-reactive regulatory t cells | |
MX2021009554A (es) | Produccion de virus en cultivos celulares. | |
FR2898275B1 (fr) | Cellules t regulatrices cd4+cd25+specifiques pour la greffe de cellules hematopoietiques et la tolerance immunitaire | |
NZ603863A (en) | Concentration and lyophilization of influenza vaccine antigens | |
IN2015DN00924A (pl) | ||
IL246525B (en) | Pomegranate cell culture and methods for its preparation and use | |
RU2012127158A (ru) | Способ терапии ремиттирующего рассеянного склероза | |
MY179888A (en) | Autologous tissue-engineered human skin construct and a method for producing thereof | |
IN2014DN10408A (pl) |